General Study confirms continued effectiveness of antibodies and vaccines used to prevent RSV infectionsBy Healthcare Propulsion StaffSeptember 16, 20260 An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants associated…
General Insilico Medicine launches AI initiative to develop longevity vaccinesBy Healthcare Propulsion StaffSeptember 15, 20260 Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced Longevity Vaccines, a research initiative developing treatments…
General Study shows mRNA vaccines trigger more diverse flu antibody responsesBy Healthcare Propulsion StaffSeptember 11, 20260 Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and durability of vaccine-induced antibody…
